← Leaderboards
Nelson Ruiz-Opazo
Boston University Medical Campus
$8,357,592
Attributed
$8,660,092
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,660,092 · 7
By mechanism
R01$7,434,467 · 5
R21$1,225,625 · 2
Top collaborators
- Mark W Grinstaff2 shared
- Victoria L Herrera2 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Richard David Wainford$14,097,365
- Victoria L Herrera$5,112,477
Others in their field
Top investigators on “Essential Hypertension”
- Pedro A. Jose · George Washington University$30,380,733
- Aravinda Chakravarti · Johns Hopkins University$16,287,149
- Vincent C. Hascall · Cleveland Clinic Foundation$16,073,487
- Frank A Treiber · Medical College Of Georgia (Mcg)$12,533,101
- Stephanie W Watts · Michigan State University$11,542,021
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$10,791,888
Research focus
Essential HypertensionBlood PressureHypertensionLaboratory RatGenetically Modified AnimalsFemaleStrokeInvestigationMaleOrganPredispositionPrevention StrategyGeneticBaseResistanceSalt SensitiveAngiotensin /Renin /Aldosterone HypertensionQuantitative Trait LociRattusGene Environment InteractionGenetic SusceptibilityEtiologyLaboratory MouseTrait
Grant awards (24)
Multi-functional targeted bio-conjugate platform to dismantle neutrophil extracellular traps (NETs)$247,500
R21 · FY2020 · HL
Multi-functional targeted bio-conjugate platform to dismantle neutrophil extracellular traps (NETs)$206,250
R21 · FY2019 · HL
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension$382,883
R01 · FY2013 · HL · contact PI
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension$402,188
R01 · FY2012 · HL · contact PI
Gender-specific genetic determinants of hypertension and end organ disease$406,250
R01 · FY2011 · HL · contact PI
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension$406,250
R01 · FY2011 · HL · contact PI
Functional characterization of ATP1A1 and DEspR variants associated with essentia$406,250
R21 · FY2010 · HL · contact PI
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension$406,250
R01 · FY2010 · HL · contact PI
Gender-specific genetic determinants of hypertension and end organ disease$406,250
R01 · FY2010 · HL · contact PI
Gender-specific genetic determinants of hypertension and end organ disease$406,250
R01 · FY2009 · HL · contact PI
Functional characterization of ATP1A1 and DEspR variants associated with essentia$365,625
R21 · FY2009 · HL · contact PI
Gender-specific genetic determinants of hypertension and end organ disease$406,250
R01 · FY2008 · HL · contact PI
Molecular Genetics of the ET-1/AngII Receptor$403,750
R01 · FY2005 · HL
Role of Na+ Transporter Genes in Essential Hypertension$326,000
R01 · FY2005 · HL
Molecular Genetics of the ET-1/AngII Receptor$403,750
R01 · FY2004 · HL
Role of Na+ Transporter Genes in Essential Hypertension$326,000
R01 · FY2004 · HL
Molecular Genetics of the ET-1/AngII Receptor$403,750
R01 · FY2003 · HL
Role of Na+ Transporter Genes in Essential Hypertension$326,000
R01 · FY2003 · HL
Molecular Genetics of the ET-1/AngII Receptor$404,688
R01 · FY2002 · HL
Role of Na+ Transporter Genes in Essential Hypertension$326,000
R01 · FY2002 · HL
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE$323,638
R01 · FY2002 · HL
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE$313,560
R01 · FY2001 · HL
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION$358,164
R01 · FY2000 · HL
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE$296,596
R01 · FY2000 · HL